| Peroral Route: An Opportunity for Protein and Peptide Drug Delivery A Sood, R Panchagnula Chemical Reviews 101 (11), 3275-3304, 2001 | 278 | 2001 |
| Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research MVS Varma, S Khandavilli, Y Ashokraj, A Jain, A Dhanikula, A Sood, ... Current drug metabolism 5 (5), 375-388, 2004 | 124 | 2004 |
| Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method R Panchagnula, A Sood, N Sharda, K Kaur, CL Kaul Journal of pharmaceutical and biomedical analysis 18 (6), 1013-1020, 1999 | 112 | 1999 |
| Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index A Sood, R Panchagnula International journal of pharmaceutics 261 (1-2), 27-41, 2003 | 99 | 2003 |
| Drug release evaluation of diltiazem CR preparations A Sood, R Panchagnula International Journal of Pharmaceutics 175 (1), 95-107, 1998 | 94 | 1998 |
| Role of dissolution studies in controlled release drug delivery systems A Sood, R Panchagnula STP pharma sciences 9 (2), 157-168, 1999 | 57 | 1999 |
| Circadian rhythm and drug delivery design SP Vyas, A Sood, P Venugopalan, N Mysore Die Pharmazie 52 (11), 815-820, 1997 | 41 | 1997 |
| Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes. SP Vyas, P Venugopalan, A Sood, N Mysore Die Pharmazie 52 (5), 339-345, 1997 | 20 | 1997 |
| Controlled-Release Dosage Forms for Diltiazem Hydrochloride A Sood, Y Ashokraj, R Panchagnula Pharmaceutical Technology, 2004 | 17 | 2004 |
| A multiunit matrix-based particulate system for controlled delivery of nifedipine A SOOD, Y ASHOKRAJ, R PANCHAGNULA Pharmaceutical technology (2003) 28 (11), 84-102, 2004 | 13 | 2004 |
| Analysis of frusemide and spironolactone mixtures using first‐derivative spectrophotometry R PANCHAGNULA, K KAUR, A SOOD, I SINGH Pharmacy and Pharmacology Communications 3 (8), 425-429, 1997 | 13 | 1997 |
| Preparation and characterization of microencapsulated gelospheres for controlled oral theophylline delivery SP Vyas, ASP Venugopalan, N Venkatesan Journal of microencapsulation 17 (6), 767-775, 2000 | 12 | 2000 |
| tablet dosage form comprising cetirizine and pseudoephedrine BK Padhi, A Sood, AK Rampal US Patent App. 12/303,609, 2010 | 11 | 2010 |
| Controlled ocular drug delivery and vesicular systems: an overview N Mysore, A Sood, P Venugopalan, SP Vyas Indian drugs 33 (9), 431-442, 1996 | 8 | 1996 |
| Analysis of rifampicin and its main metabolite in presence of pyrazinamide and isoniazid in plasma and urine samples by HPLC method R Panchagnula, A Sood, N Sharda, KJ Kaur, CL Kaul J Pharm Biomed Anal 18, 1505-1022, 1999 | 7 | 1999 |
| Synthetic peptides: a modern approach to vaccination. A Sood, P Venugopalan, N Mysore, SP Vyas Indian journal of experimental biology 36 (9), 849-861, 1998 | 7 | 1998 |
| Liposomes in cosmetics and skin care A Sood, P Venugopalan, N Venkatesan, SP Vyas Indian drugs 33 (2), 43-49, 1996 | 6 | 1996 |
| Prospects of integrated collaborative technology of carbon dioxide capture S Vyas, VK Sethi, JS Chouhan, A Sood 32nd national convention of environmental engineers: challenges in …, 2016 | 5 | 2016 |
| Development and in-vitro evaluation of matrix based CR pellets for Diltiazem HC*** 1 using extrusion and spheronization A Sood, R Panchagnula Journal of Pharmacy and Pharmacology 50 (Supplement_9), 181-181, 1998 | 2 | 1998 |
| Drug release evaluation of Diltiazem HCl CR preparations A Sood, R Panchagnula Journal of Pharmacy and Pharmacology 50 (Supplement_9), 179-179, 1998 | 2 | 1998 |
